ArticleScience advances2025
Amorphous monolayer CuPd catalysts for selective semihydrogenation.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Boron-assisted synthesis of compositionally complex amorphous oxides via short-range-order-constrained generative design.Science advances · 2026Article
- Synergistic Mechanism of Carbon-Based Dual-Metal-Atom Catalysts: Breakthroughs in Atomic Precision Regulation and Enhanced Electrocatalytic Performance.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Transient Laser-Shocked Synthesis of Amorphous Layer-Supported Metal Nanocrystals for Efficient Nitrate Reduction.Advanced materials (Deerfield Beach, Fla.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The unique structural configuration of amorphous nanomaterials, characterized by their disordered atomic arrangements, highly exposed active sites, and isotropic homogeneity, enables exceptional catalytic performance that bridges the gap between homogeneous and heterogeneous catalysis. In this work, an amorphous CuPd catalyst was fabricated through incorporating Cu ions into the disordered Pd lattice, creating an amorphous monolayer architecture with engineered hydrogen transport pathways. The precisely modulated atomic/electronic configuration optimizes the adsorption configuration and bonding strength between substrate/intermediates and catalysts surfaces. The amorphous catalyst achieves 96.2% selectivity at 99.1% conversion under mild conditions, with a time of flight of 6004 hour
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.